BLAIR HOFFMAN: Open Payments
NPI 1407227606 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 29 payments from 16 companies in 2025. Trend: 2023 $702 · 2024 $536 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $112 |
| SANOFI-AVENTIS U.S. LLC | 4 | $86 |
| Astellas Pharma US Inc | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $43 |
| Amgen Inc. | 3 | $42 |
| Novo Nordisk Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| ARGENX US, INC. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: Bimzelx, TZIELD, REXULTI, Veozah, TREMFYA, ZEPBOUND, VYVGART HYTRULO, INSPIRE.
Industry payments across GA — which companies pay providers there.
